Broggini M - Search Results

1

KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells.

Rampino T, Gregorini M, Guidetti C, Broggini M, Marchini S, Bonomi R, Maggio M, Roscini E, Soccio G, Tiboldo R, Dal Canton A. Rampino T, et al. Among authors: broggini m. Growth Factors. 2007 Dec;25(6):382-91. doi: 10.1080/08977190801892184. Growth Factors. 2007. PMID: 18365869

2

New molecules and strategies in the field of anticancer agents.

Marchini S, D'Incalci M, Broggini M. Marchini S, et al. Among authors: broggini m. Curr Med Chem Anticancer Agents. 2004 May;4(3):247-62. doi: 10.2174/1568011043352966. Curr Med Chem Anticancer Agents. 2004. PMID: 15134503 Review.

3

P53-independent caspase-mediated apoptosis in human leukaemic cells is induced by a DNA minor groove binder with antineoplastic activity.

Marchini S, Ciro' M, Broggini M. Marchini S, et al. Among authors: broggini m. Apoptosis. 1999 Feb;4(1):39-45. doi: 10.1023/a:1009630132087. Apoptosis. 1999. PMID: 14634294

4

Questioning the oncogenic role of DeltaNp73alpha in different cell lines expressing p53 or not.

Marrazzo E, Marchini S, Previdi S, Broggini M. Marrazzo E, et al. Among authors: broggini m. Cancer Biol Ther. 2006 Jul;5(7):794-803. doi: 10.4161/cbt.5.7.2753. Epub 2006 Jul 28. Cancer Biol Ther. 2006. PMID: 16721041 Free article.

5

Analysis of gene expression in early-stage ovarian cancer.

Marchini S, Mariani P, Chiorino G, Marrazzo E, Bonomi R, Fruscio R, Clivio L, Garbi A, Torri V, Cinquini M, Dell'Anna T, Apolone G, Broggini M, D'Incalci M. Marchini S, et al. Among authors: broggini m. Clin Cancer Res. 2008 Dec 1;14(23):7850-60. doi: 10.1158/1078-0432.CCR-08-0523. Clin Cancer Res. 2008. PMID: 19047114

6

Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.

Colella G, Marchini S, D'Incalci M, Brown R, Broggini M. Colella G, et al. Among authors: broggini m. Br J Cancer. 1999 May;80(3-4):338-43. doi: 10.1038/sj.bjc.6690360. Br J Cancer. 1999. PMID: 10408835 Free PMC article.

7

Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743.

Marchini S, Marrazzo E, Bonomi R, Chiorino G, Zaffaroni M, Weissbach L, Hornicek FJ, Broggini M, Faircloth GT, D'Incalci M. Marchini S, et al. Among authors: broggini m. Eur J Cancer. 2005 Jan;41(2):323-33. doi: 10.1016/j.ejca.2004.10.021. Eur J Cancer. 2005. PMID: 15661559

8

Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.

Sabatino MA, Colombo T, Geroni C, Marchini S, Broggini M. Sabatino MA, et al. Among authors: broggini m. Clin Cancer Res. 2003 Nov 1;9(14):5402-8. Clin Cancer Res. 2003. PMID: 14614026

9

Development of distamycin-related DNA binding anticancer drugs.

Marchini S, Broggini M, Sessa C, D'Incalci M. Marchini S, et al. Among authors: broggini m. Expert Opin Investig Drugs. 2001 Sep;10(9):1703-14. doi: 10.1517/13543784.10.9.1703. Expert Opin Investig Drugs. 2001. PMID: 11772279 Review.

10

P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

Vikhanskaya F, Marchini S, Marabese M, Galliera E, Broggini M. Vikhanskaya F, et al. Among authors: broggini m. Cancer Res. 2001 Feb 1;61(3):935-8. Cancer Res. 2001. PMID: 11221886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters